Navigation Links
OHK Medical Devices to Exhibit at 2013 American Academy of Orthopedic Surgeons (AAOS) in Chicago
Date:2/28/2013

Chicago, IL (PRWEB) February 28, 2013

OHK Medical Devices Ltd., manufacturer of the HemaClear® single-use, sterile exsanguinating tourniquet device, announced today that it will be exhibiting at the 2013 American Academy of Orthopedic Surgeons (AAOS). The meeting will take place March 20th through the 22nd in Chicago. The company is excited to celebrate major clinical milestones and increase the presence of the growing tourniquet of choice.

In 2012 OHK Medical Devices celebrated the 500,000 application of HemaClear®. Further, it celebrated the successful launch of HemaClear® in multiple countries including Australia, France and South Korea.

“We are very excited to showcase our tourniquet technology at the AAOS. The conference provides a unique opportunity to introduce surgeons to the first innovation in the field in over a century" said Omer Inbar, VP of Sales, OHK Medical Devices. Mr. Inbar added that “After a very strong year in 2012, we are off to a fantastic start in 2013 as HemaClear sales continue to take off. Our current expansion efforts combine creating a presence in new markets such as Latin America, Eastern Europe and Scandinavia and deepening our footprint in the existing markets in Europe and the US.”

OHK Medical Devices will be exhibiting in the main hall of the McCormick Center booth #1108. Surgeons and industry professionals are urged to come by the booth and learn why HemaClear® is quickly becoming the global tourniquet of choice.

About HemaClear®
HemaClear® is the world’s leading sterile tourniquet with a simple yet innovative technology, representing a new standard of care in bloodless orthopedic surgery. Since entering the market in 2007 this product has been successfully used in almost 500,000 procedures. Easier, cheaper and safer than the standard offerings, HemaClear® represents the first significant advancement in tourniquet technology in over 100 years. HemaClear® was developed by OHK Medical Devices (OHK), a privately held company based in Haifa, Israel and the United States and is currently used in over 2000 operating rooms across 30 countries. For more information about HemaClear®, visit http://www.hemaclear.com.

Read the full story at http://www.prweb.com/releases/2013/2/prweb10472923.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. Clinovo, Leading CRO in the Bay Area, Endorsed by Medical Device Company for Their Flagship System: Clincapture
2. IpAuctions™, Inc. "All Things Medical" Auction event is opening March, 2013.
3. Foundation for the NIH Announces Lurie Prize Recognizing Outstanding Achievement by a Young Biomedical Scientist
4. Palomar Medical Center in San Diego County Introduces New Wrist-Worn Wireless Patient Vital Signs Device
5. Quantason Names Dr. Ellen B. Mendelson, Medical Director
6. R&D, Innovation Key to Success - Research Report on Varian Medical Systems, Inc., Boston Scientific Corporation, Stryker Corporation, St. Jude Medical, Inc., and Thermo Fischer Scientific Inc.
7. Vista College Introduces Its New Medical Laboratory Technician Diploma Program At El Paso Campus
8. Vermillion to Participate in Lazard Capital Markets 5th Annual Medical Technology Snowbird Conference on February 27, 2013
9. Nasseo, Inc. Joins BioInspire™ Medical Technology Incubator, Closes Seed Funding Round
10. University of Colorado Cancer Center Study Shows the Preferred Feeding Method is not the Medically Best in Malnourished Pediatric Cancer Patients
11. Bluestar Silicones Presents Soft Silicone Advantages At Medical Design And Manufacturing (MD&M) West Show
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/27/2016)... ... ... Global Stem Cells Group and the University of Santiago Biotechnology ... development initiatives for potential stem cell protocol management for 2016 – 2020. , ... meeting to establish a working agenda and foster initiatives to promote stem cell research ...
(Date:4/26/2016)... , ... April 26, 2016 , ... The European ... been selected as one of three finalists for the European Inventor Award 2016 in ... innovation prize will be announced at a ceremony in Lisbon on June 9th. , ...
(Date:4/26/2016)... Seattle, Washington (PRWEB) , ... April 26, 2016 ... ... (IVS) today announced receipt of a significant operating grant from 1Plus12 Corporation. The ... and to commence pre-proposal activities as outlined on the organization's website http://www.ivsci.org ...
(Date:4/26/2016)... 2016 Celsion Corporation (NASDAQ: CLSN ... that the first patient in China ... global Phase III OPTIMA Study evaluating ThermoDox®, Celsion,s ... with radiofrequency ablation standardized to 45 minutes (sRFA) ... with primary liver cancer, also known as hepatocellular ...
Breaking Biology Technology:
(Date:3/22/2016)... and SANDY, Utah , March ... operates the highest sample volume laboratory in ... and UNIConnect, leaders in clinical sequencing informatics and molecular ... of a project to establish the informatics infrastructure for ... NSO has been contracted by the Ontario Ministry ...
(Date:3/15/2016)... York , March 15, 2016 ... market report published by Transparency Market Research "Digital Door Lock ... and Forecast 2015 - 2023," the global digital door lock ... 731.9 Mn in 2014 and is forecast to grow at ... Growth of micro, small and medium enterprises (MSMEs) across the ...
(Date:3/11/2016)... 11, 2016 http://www.apimages.com ) - --> ... is available at AP Images ( http://www.apimages.com ) - ... used to produce the new refugee identity cards. DERMALOG will be ... CeBIT in Hanover next week.   --> ... be used to produce the new refugee identity cards. DERMALOG will ...
Breaking Biology News(10 mins):